Could a cell infusion free liver transplant patients from lifelong drugs?
Disease control
Completed
This study tested whether an infusion of special immune cells (regulatory dendritic cells) from the donor could help liver transplant recipients safely reduce their anti-rejection medications. Sixteen low-risk patients received the cell infusion a week before transplant, then fol…
Phase: PHASE1, PHASE2 • Sponsor: Angus W. Thomson PhD DSc • Aim: Disease control
Last updated Jun 26, 2026 18:28 UTC